Lantern Pharma Inc. (LTRN) Discusses Live Demonstration of withZeta.ai AI Platform for Rare Cancer Drug Discovery Transcript

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

OpenAI Boasts Recursive AI: 3 Examples

OpenAI advances recursive AI; new startup pursues self-improving systems amid leaked experimental model names.
Microsoft

When prompts become shells: RCE vulnerabilities in AI agent frameworks

New research exposes how prompt injection in AI agent frameworks can lead to remote code execution. Learn how these ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
BioSpace

Patient advocate offers Recursion a powerful reason to keep going in rare disease

Staff at Salt Lake City-based techbio company Recursion recently heard from Jenny and Tim Jones about their challenging ...
pharmaphorum

Change at the top of Recursion as co-founder leaves CEO role

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
International Monetary Fund

IMF Financial Data Query Tool

1. Selected dates can't be greater than April 2026. 2. From date can't be greater than To date. 1. Selected dates can't be greater than April 2026. 2. From date can't be greater than To date. 1. From ...